PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40625176,"A second-generation, self-amplifying COVID-19 Vaccine: World's first approval and distribution in the Japanese market with vaccine hesitancy.",2025 Dec,,,
40624510,Dynamics of contact behaviour by self-reported COVID-19 vaccination and infection status during the COVID-19 pandemic in Germany: an analysis of two large population-based studies.,2025 Jul 7,Boff L; Harries M; Lange B,"Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany. berit.lange@helmholtz-hzi.de.",
40624462,"Safety comparison of mRNA, viral vector, and inactivated Covid-19 vaccines: incidence of adverse events following primary and booster doses among medical professionals in Malaysia.",2025 Jul 7,Thundakattil AV,"Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.",
40624061,Intranasal booster induces durable mucosal immunity against SARS-CoV-2 in mice.,2025 Jul 7,,,
40623876,Impact of vaccine mandates and removals on COVID-19 vaccine uptake in Australia and international comparators: a study protocol.,2025 Jul 7,Moore HC; Blyth CC,"Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia.",
40623118,Estimating behavioural relaxation induced by COVID-19 vaccines in the first months of their rollout.,2025 Jul 7,Gozzi N,"ISI Foundation, Turin, Italy.",
40623023,Determinants of COVID-19 vaccine uptake among persons with disabilities in three selected districts of Zambia.,2025,,,
40622951,Preparing for future pandemics: A qualitative exploration of social media in light of the COVID-19 pandemic and vaccine hesitancy.,2025,,,
40622852,Arsenic trioxide could promote SARS-CoV-2 NSP12 protein degradation.,2025 Jul,,,
40622507,"Association between Guillain-Barre syndrome and SARS-CoV-2 virus infection, including the impact of COVID-19 vaccination in the context of the development and general clinical characteristics of the disease.",2025 Jul 7,,,
40620653,Incomplete systemic capillary leak syndrome after COVID-19 vaccination: a case-based review.,2025,,,
40620571,Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil.,2025,Moreira Puga MA; de Oliveira RD; Vieira da Silva P; Charu V; Seidman JC; Garret D,"Fundacao Oswaldo Cruz, Fiocruz Mato Grosso do Sul, Campo Grande, Brazil.; Fundacao Oswaldo Cruz, Fiocruz Mato Grosso do Sul, Campo Grande, Brazil.; Nursing Course, Universidade Estadual do Mato Grosso do Sul, Dourados, Brazil.; Fundacao Oswaldo Cruz, Fiocruz Mato Grosso do Sul, Campo Grande, Brazil.; Infectious Diseases and Geographic Medicine, Stanford Medicine, Stanford, California, USA.; Infectious Diseases and Geographic Medicine, Stanford Medicine, Stanford, California, USA.",
40620334,Prevalence of infection and associated factors after intramedullary nailing in African countries with the Surgical Implant Generation Network program: A systematic review and meta-analysis of available evidence.,2025,Abadi Tareke A; Andargie GA,"Amref Health Africa in Ethiopia, COVID-19 Vaccine/EPI Technical Assistant at West Gondar Zonal Health Department, Gondar, Ethiopia.; Department of Nutrition, Antsokiya Gemza District Health Office, North Shoa, Mekoy, Ethiopia.",
40619650,SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability.,2025 Jul 6,,,
40619375,Prehospital respiratory interventions during six waves of COVID-19: results from Israel's Emergency Medical Services system.,2025 Jul 6,Alpert EA; Lipsky AM; Jaffe E,"Community Division, Magen David Adom, Or Yehuda, Israel. maximilian.nerlander@liu.se.; Department of Emergency Medicine, Hadassah Medical Center, Ein Kerem, Jerusalem, Israel.; Community Division, Magen David Adom, Or Yehuda, Israel.",
40618623,"Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C.",2025 Jul 5,,,
40618408,"Analysing Adverse Event Databases: Principles, Challenges, and Examples.",2025 Aug,,,
40617765,The hypercoagulable state in COVID-19 and implications for free flap surgery in the lower limb: A retrospective multi-centre study.,2025 Jun 24,Stark D; Hendrickson S,"North Bristol NHS Trust, Bristol, United Kingdom. Electronic address: David.stark1@nhs.net.; North Bristol NHS Trust, Bristol, United Kingdom.",
40617588,Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms.,2025 Jul 5,Beretta M; Fogel O; Planchais C; Bruneau T; Goncalves P; Avouac J; Berenbaum F; Sellam J; Fautrel B; Morel J; Parfait B; Di Santo JP; Behillil S; van der Werf S; Pere H; Mouquet H; Miceli-Richard C,"Humoral Immunology Unit - INSERM U1222, Institut Pasteur and Universtity Paris Cite, Paris, France.; Department of Rheumatology, Hopital Cochin - Assistance Publique Hopitaux de Paris - Universite Paris Cite, Paris, France.; Humoral Immunology Unit - INSERM U1222, Institut Pasteur and Universtity Paris Cite, Paris, France.; Service de Microbiologie (Unite de virologie), Hopital Europeen Georges Pompidou, Paris, France.; Inserm U1223, Innate Immunity Unit, Institut Pasteur, Paris, France.; Department of Rheumatology, Hopital Cochin - Assistance Publique Hopitaux de Paris - Universite Paris Cite, Paris, France.; Faculty of Medicine Pierre & Marie Curie Paris VI, Hopital Saint-Antoine, Paris, France.; Faculty of Medicine Pierre & Marie Curie Paris VI, Hopital Saint-Antoine, Paris, France.; Department of Rheumatology, Hopital Cochin - Assistance Publique Hopitaux de Paris - Universite Paris Cite, Paris, France.; Immunorhumatologie, CHU Lapeyronie, Montpellier, France.; Centre de Ressources Biologique - Hopital Cochin - Federation des Centres de Ressources Biologiques-, Assistance Publique Hopitaux de Paris - Universite Paris Cite, Paris, France.; Inserm U1223, Innate Immunity Unit, Institut Pasteur, Paris, France.; UMR 3569 CNRS, Molecular Genetics of RNA Viruses, National Reference Center Respiratory Viruses, Institut Pasteur, Paris, France.; UMR 3569 CNRS, Molecular Genetics of RNA Viruses, National Reference Center Respiratory Viruses, Institut Pasteur, Paris, France.; Service de Microbiologie (Unite de virologie), Hopital Europeen Georges Pompidou, Paris, France.; Humoral Immunology Unit - INSERM U1222, Institut Pasteur and Universtity Paris Cite, Paris, France.; Immunoregulation Unit, Institut Pasteur, Paris, France corinne.miceli@aphp.fr.",
40617558,The effect of COVID-19 vaccination on menstrual cycles of adolescents and young adults: a systematic review and meta-analysis.,2025 Jul 3,,,
40617534,Scalable approach for Coronavirus-like particles making based on the Spike protein using Sf9 cells.,2025 Jul 3,Coelho de Oliveira H,"Eppendorf do Brasil Ltda. Rua Presidente Antonio Candido, 80, CEP 05083-060, Sao Paulo, SP-Brazil.",
40617406,Erythema Papulatum Centrifugum: A Clinically Distinct Dermatosis. CLINI-AEDV Case Series.,2025 Jul 3,Ballester-Nortes I; Fernandez-Tapia V; Parera-Amer ME,"Servicio de Dermatologia. H.U. Morales Meseguer, Murcia, Spain.; Servicio de Dermatologia. H.U. Son Llatzer, Palma, Spain.; Servicio de Dermatologia. H.U. Son Llatzer, Palma, Spain.",
40617090,Duration of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after primary homologous vaccination or first infection.,2025 Jul 4,,,
40617089,Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.,2025 Jul 4,Ansah NA; Obaro S; Jambo K; Sow S; Kagucia EW; Chicumbe S; Dlamini T; Browne M; Clothier H; Griffin J; Jiang Y; Lee A; Ghebreab L; Black SB,"Navrongo Health Research Centre, Navrongo, Ghana. Electronic address: nana.ansah@navrongo-hrc.org.; International Foundation Against Infectious Disease (IFAIN), Abuja, Nigeria. Electronic address: stephenson255@gmail.com.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi. Electronic address: kjambo@mlw.mw.; Centre for Vaccine Development (CVD), Mali, Bamako. Electronic address: ssow@cvd-mali.org.; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. Electronic address: EKagucia@kemri-wellcome.org.; Instituto Nacional de Saude, Mozambique. Electronic address: sergio.chicumbe@ins.gov.mz.; National Immunization Programme, Eswatini.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: m.browne@auckland.ac.nz.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: hazel.clothier@mcri.edu.au.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: jennifer.griffin@auckland.ac.nz.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: y.jiang@auckland.ac.nz.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: arier.lee@auckland.ac.nz.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: luam.ghebreab@auckland.ac.nz.; Global Vaccine Data Network, Auckland, New Zealand. Electronic address: stevblack@gmail.com.",
40616520,Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19.,2025 Jul 5,Unoh Y; Hirai K; Uehara S; Kawashima S; Nobori H; Sato J; Shibayama H; Hori A; Nakahara K; Kurahashi K; Takamatsu M; Yamamoto S; Zhang Q; Tanimura M; Dodo R; Maruyama Y; Kato T; Sato T; Tachibana Y,"Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Global Virus Network, 12901 Bruce B. Downs Blvd. MDC02, Tampa, Florida 33612, United States.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.; Shionogi Pharmaceutical Research Center, 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.",
40615384,Hamsters immunized with formalin-inactivated SARS-CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection.,2025 Jul 4,Bewley KR; Hall Y; Salguero FJ,"United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK.; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK.; United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK.",
40615136,Gender disparities in COVID-19 vaccine hesitancy in high-income countries: an umbrella review protocol.,2025 Jul 3,Noviello C; Palmieri C; Stefanizzi P; Tafuri S,"Department of Biomedical Science and Human Oncology, Universita degli Studi di Bari Aldo Moro, Bari, Italy.; Department of Biomedical Science and Human Oncology, Universita degli Studi di Bari Aldo Moro, Bari, Italy.; Department of Biomedical Science and Human Oncology, Universita degli Studi di Bari Aldo Moro, Bari, Italy.; Department of Biomedical Science and Human Oncology, Universita degli Studi di Bari Aldo Moro, Bari, Italy.",
40614182,Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.,2025 Jul 4,Jin H; Knopp K; Radziewicz H; Tellier M; Li Z; Gingerich MC; Wu S,"CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.; CyanVac LLC, 111 Riverbend Rd, Athens, GA 30602, USA.",
40614084,Using Large Language Models to Assess Burnout Among Health Care Workers in the Context of COVID-19 Vaccine Decisions and Health Beliefs: Retrospective Cohort Study.,2025 Jul 4,,,
40613499,A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.,2025 Dec,,,
40613498,Hydrophobin-Fused SARS-CoV-2 RBD production in Nicotiana benthamiana L. for COVID-19 serology.,2025 Dec,,,
40613193,[Interaction between COVID-19 Infection and Hematological Malignancies --Review].,2025 Jun,,,
40613099,"COVID-19 knowledge, attitudes and practices in Thabo Mofutsanyana District, South Africa, 2022.",2025,Mayet N,"Gauteng City-Region Observatory, Johannesburg, South Africa.",
40613010,COVID-19 Hospitalization and Mortality Trends Among US Dialysis Patients by Race/Ethnicity and Vaccination Status.,2025 Jul,Shieu MM; Weiner DE; Li NC; Manley HJ; Harford A; Hsu CM; Miskulin D; Johnson D; Lacson EK Jr,"Quality Analytics, Dialysis Clinic Inc., Nashville, TN.; William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA.; Quality Analytics, Dialysis Clinic Inc., Nashville, TN.; Quality Analytics, Dialysis Clinic Inc., Nashville, TN.; Quality Analytics, Dialysis Clinic Inc., Nashville, TN.; William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA.; William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA.; Quality Analytics, Dialysis Clinic Inc., Nashville, TN.; Quality Analytics, Dialysis Clinic Inc., Nashville, TN.",
40612481,Pre-post data from a cogenerational health outreach program within federally qualified health centers: experiences in the encore intergenerational vaccine corps and assessments of different generations and public issues.,2025 Aug,,,
40612208,Myocarditis Following COVID-19 Vaccine: What Did We Learn?,2025 Jan-Dec,,,
40612010,A scoping review of authorisation pathway for COVID-19 vaccines among selected countries.,2025,Suphap S,"Medicines Regulation Division, Thailand Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand.",
40611257,Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants.,2025 Jul 3,Li Y; He Y; He X,"Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 511430, China.; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 511430, China.; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 511430, China.",
40611132,Role of senescent CD4(+) T cells in breakthrough infection of the new variant strain of SARS-CoV-2 in elderly patients.,2025 Jul 3,,,
40610704,Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review.,2025 Jul 3,Cahuapaza-Gutierrez NL; Calderon-Hernandez CC; Villavicencio-Escudero TV,"Universidad Cientifica del Sur, Lima, Peru.; CHANGE Research Working Group, Universidad Cientifica del Sur, Lima, Peru.; Research Department, Center of Research and Medical Excellence (CRME), N y C, Lima, Peru.",
40610585,Differential immunity induced by Omicron sublineages in naive and vaccine breakthrough infections.,2025 Jul 3,,,
40609994,Multiepitope mRNA Vaccine mRNA-mEp21-FL-IDT Provides Efficient Protection against M. tuberculosis.,2025 Jun,,,
40609264,Education as a mediator of ethnic disparities in adult COVID-19 vaccination in Peru.,2025 Jul 2,Al-Kassab-Cordova A; Mezones-Holguin E,"Centro de Excelencia en Investigaciones Economicas y Sociales en Salud, Universidad San Ignacio de Loyola, Lima, Peru. Electronic address: aliac1998@gmail.com.; Centro de Excelencia en Investigaciones Economicas y Sociales en Salud, Universidad San Ignacio de Loyola, Lima, Peru; Epignosis Solutions, Piura, Peru.",
40609262,"COVID-19 vaccine uptake and effectiveness among people with recent history of injection drug use in British Columbia, Canada: A retrospective analysis.",2025 Jul 2,Wilton J; Crabtree A,"British Columbia Centre for Disease Control, Vancouver, BC, Canada.; British Columbia Centre for Disease Control, Vancouver, BC, Canada.",
40609232,The COVID-19 vaccination health literacy questionnaire (CVHL-Q): Design and validation according to classic psychometric and Rasch analyses.,2025 Jul 2,,,
40609106,Correspondence on incidence and factors associated with adverse reactions after the first dose of COVID-19 vaccine.,2025,Kleebayoon A,"Consultant Unit, Private Academic Consultant, Samraong, Cambodia.",
40608738,"Uptake, knowledge, attitudes, and practices toward seasonal influenza vaccination among community healthcare workers during the COVID-19 pandemic in Chongqing Municipality, China: A cross-sectional study.",2025,Yang X; Lv X; Wang Q; Wang D; Ding X; Chen T,"Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.; Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.",
40608708,A survey on the situation and risk factors of secondary infection after the second wave of the Omicron COVID-19 in China.,2025 Jun 30,,,
40608426,MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury.,2025 Jul 3,Alipanah-Lechner N; Langelier CR; Erle DJ; Eckalbar WL; Network I; Calfee CS; Aguilar OA; Greenland JR; Calabrese DR,"Department of Medicine, UCSF, San Francisco, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.; IMPACC Network, Boston, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.; Department of Microbiology and Immunology, UCSF, San Francisco, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.; Department of Medicine, UCSF, San Francisco, United States of America.",
40607738,Rebuilding vaccine confidence in Latin America and the Caribbean: strategies for the post-pandemic era.,2025 Dec,Debbag R; Gallo J; Beltran C; Brea-Del Castillo J; Puentes A; Enrique S,"Latin-American Vaccinology Society, SLV, Buenos Aires, Argentina.; Immunizations Committee, Latin American Society of Pediatric Infectious Diseases, SLIPE, Buenos Aires, Argentina.; Latin American Society of Pediatric Infectious Diseases, SLIPE, San Jose, Costa Rica.; Latin American Vaccinology Society, SLV, San Jose, Costa Rica.; Pediatric Infectious Diseases Committee, Pediatric Society of Colombia (SPC), Medellin, Colombia.; Latin American Society of Pediatric Infectious Diseases, SLIPE, Medellin, Colombia.",
40607311,Vaccine hesitancy in an allergy and immunology clinic in an underserved community.,2025 Aug,Silverberg N; Bao H,"Maimonides Medical Center, Brooklyn, NY.; Maimonides Medical Center, Brooklyn, NY.",
40607264,[Vaccination coverage against COVID-19 in healthcare workers and associated factors in the city of Yaounde in July 2022].,2025,Koingakiawa SOB; Nzougouat JL; Edzoa BE; Tonga C,"Ecole des Sciences de Sante, Universite Catholique d'Afrique Centrale, Yaounde, Cameroun.; Institut de Formation et de Recherche Demographique, Yaounde, Cameroun.; Delegation Regionale de la Sante Publique du Centre, Yaounde, Cameroun.; Programme Elargi de Vaccination, Ministere de la Sante Publique, Yaounde, Cameroun.",
40607207,"RECOVID: Retrospective Observational Study of Renal Outcomes and Long-Term Mortality in Patients With COVID-19-Associated AKI, A Comparison Between Vaccinated and Unvaccinated Patients.",2025 Jul,,,
40604541,"Epidemiological trends of hand, foot, and mouth disease in children under age 10, Jiangning District, Jiangsu, China (2009-2023).",2025 Jul 2,Wu B; Fu M,"The Jiangning District Center for Disease Control and Prevention, Nanjing, China.; The Jiangning District Center for Disease Control and Prevention, Nanjing, China.",
40604011,Age associated SARS-CoV-2 immune responses provide insights into population immunity over four years since the COVID-19 pandemic.,2025 Jul 2,Duangchinda T; Nilyanimit P,"Molecular Biology of Dengue and Flaviviruses Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Development Agency, NSTDA, Pathum Thani, 12120, Thailand.; Molecular Biology of Dengue and Flaviviruses Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Development Agency, NSTDA, Pathum Thani, 12120, Thailand.",
40603330,"Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.",2025 Jul 2,,,
40603140,"Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: Systematic review and meta-analysis.",2025 Jul 1,,,
40602456,Chaperone Activity of SARS-CoV-2 Nucleocapsid Protein: RNA Annealing and Destabilization Mechanisms.,2025 Jun 30,,,
40602369,"Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Coronavirus Disease 2019 Vaccination Trends: Findings from Surveillance Conducted at First Antenatal Care Visits in Kenya, Nigeria, Malawi, Mozambique, Uganda, and Zambia, 2021-2022.",2025 Jul 1,Seffren V; Yadav R; Iriemenam NC; Ajayi O; Ogunsola O; Mulube C; Ogollah F; Rogier E; Gutman JR,"Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.; Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.; CDC Nigeria, Division of Global HIV and TB, U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.; APIN Public Health Initiatives, Nigeria, Abuja, Nigeria.; APIN Public Health Initiatives, Nigeria, Abuja, Nigeria.; PATH, Lusaka, Zambia.; ICAP Malawi, Lilongwe, Malawi.; Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.; Malaria Branch, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.",
40602349,Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap.,2025 Jul 1,Ostrowsky JT; Vestin NC; Mehr AJ; Ulrich AK; Bigalke L; Bresee JS; Friede MH; Klugman KP; Nakakana UN; Wang TY; Weller CL; Osterholm MT; Lackritz EM; Moore KA,"Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America. Electronic address: jto@umn.edu.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; The Task Force for Global Health, Atlanta, GA, USA.; World Health Organization, Geneva, Switzerland.; The Gates Foundation, Seattle, Washington, USA.; The Gates Foundation, Seattle, Washington, USA.; Wellcome Trust, London, United Kingdom.; Wellcome Trust, London, United Kingdom.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America.; Center for Infectious Disease Research and Policy, C315 Mayo Memorial Building, MMC 263, 420 Delaware Street, SE, Minneapolis, MN 55455. 612-626-6770, United States of America. Electronic address: kamoore@umn.edu.",
40602344,"COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada.",2025 Jul 1,Habanyama M; McCullagh J; Moqueet N; Nambiar D,"CIHR Canadian HIV Trials Network, 1081 Burrard Street Vancouver, BC V6Z 1Y6, Canada; Ontario AIDS Network, 110 Yonge Street, Suite 401, Toronto, ON M5C 1T4, Canada.; HQ Health Hub, 790 Bay Street, Suite 820, P.O. Box 66, Toronto, ON M5G 1N8, Canada.; Public Health Agency of Canada, Old City, 785 Carling Avenue, Ottawa, ON K1A 0K9, Canada.; Gay Men's Sexual Health Alliance, 401-110 Yonge Street, Toronto, ON M5C 1T4, Canada. Electronic address: dnambiar@gmsh.ca.",
40602343,"Parental reasons for non-receipt of influenza vaccination among children 6 months-17 years and changes over time, 2015-2024.",2025 Jul 1,Kahn KE; Santibanez TA; Jain A; Zhou T; Black CL,"Eagle Health Analytics, 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092, USA; National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30329, USA. Electronic address: xdo9@cdc.gov.; National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30329, USA.; Eagle Health Analytics, 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092, USA; National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30329, USA.; Eagle Health Analytics, 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092, USA; National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30329, USA.; National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA 30329, USA.",
40601320,Hurdles for the Delivery of Multinational Randomized Clinical Trials.,2025 Jul 1,Mouncey P; Harrison D; Derde L; Hays LM; Nichol A; Torre-Cisneros J,"Intensive Care National Audit and Research Centre, London, United Kingdom.; Intensive Care National Audit and Research Centre, London, United Kingdom.; European Clinical Research Alliance on Infectious Diseases, Utrecht, the Netherlands.; Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Tours, France.; European Clinical Research Alliance on Infectious Diseases (Ecraid), Utrecht, the Netherlands.; European Clinical Research Alliance on Infectious Diseases (Ecraid), Utrecht, the Netherlands.",
40600480,Strategies for implementing long-acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study.,2025 Jul,Nelson KL; Evans Cooper T; Lawson Y; Mocherla S; Dyson A; Sutherland-Philips D; Swygard H; Petty L; Jeffery P; Sutton K; Bonner CP; Andrews SM; Chang S; Budnik P; Smith K; de Ruiter A; Czarnogorski M; Pilgrim N,"ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, Durham, North Carolina, USA.; MadeWell OBGYN, Dallas, Texas, USA.; Legacy Community Health Services, Houston, Texas, USA.; ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, Durham, North Carolina, USA.; GSK, London, UK.; ViiV Healthcare, Durham, North Carolina, USA.; RTI International, Research Triangle Park, North Carolina, USA.; RTI International, Research Triangle Park, North Carolina, USA.; RTI International, Research Triangle Park, North Carolina, USA.; ViiV Healthcare, London, UK.; ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, London, UK.; ViiV Healthcare, Durham, North Carolina, USA.; ViiV Healthcare, Durham, North Carolina, USA.",
40600163,Barriers to vaccine acceptance and immunization coverage in Kazakhstan: a mixed-methods study using the COM-B framework.,2025,Kassabekova L; Smagul M; Nukenova G; Satayeva A; Aubakirova B; Yesmagambetova A,"Scientific and Practical Center for Sanitary and Epidemiological Expertise, Astana, Kazakhstan.; National Center for Public Health, Astana, Kazakhstan.; National Center for Public Health, Astana, Kazakhstan.; Scientific and Practical Center for Sanitary and Epidemiological Expertise, Astana, Kazakhstan.; National Center for Public Health, Astana, Kazakhstan.; National Center for Public Health, Astana, Kazakhstan.",
40599452,Safflower-Derived Cationic Lipid Nanoparticles: Potential Impact on the Delivery of SARS-CoV-2 MRNA Transcripts.,2024 Dec,Nasr Isfahani H; Hariri AA; Sharifnia Z; Moradi A,"Biotechnology Department, Behyaar Sanaat Sepahan Company, Isfahan, Iran.; Biotechnology Department, Behyaar Sanaat Sepahan Company, Isfahan, Iran.; Biotechnology Department, Behyaar Sanaat Sepahan Company, Isfahan, Iran.; Biotechnology Department, Behyaar Sanaat Sepahan Company, Isfahan, Iran.",
40599443,"Assessment of COVID-19 Vaccine Knowledge, Attitude and Practice among the General Population in Duhok Province, Kurdistan Region of Iraq: A Retrospective Cross-Sectional Study.",2024 Dec,,,
40599434,"A Concise Review of Major Challenges in the Vaccination, Diagnosis and Treatment of Novel Coronavirus Disease 2019.",2024 Dec,,,
40599414,Mental Health Consequences of COVID-19 Vaccine Side Effects: Findings From a Cross-Sectional Analysis.,2025 Jul,Zaman FB,"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Mohakhali Dhaka Bangladesh.",
40599303,The Effectiveness and Influence of COVID-19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta-Analysis.,2025,,,
40599251,"COVID-19 related symptoms and the second infection status of SARS-CoV-2 in patients with lung cancer: A single-center, six-month longitudinal observational study.",2025 Dec,,,
40599176,Participant experiences in a decentralized clinical trial using digital health technologies: The ACTIV-6 study.,2025,Dunsmore SE; Thicklin F,"National Center for Advancing Translational Sciences, Bethesda, MD, USA.; Stakeholder Advisory Committee, Pittsburgh, PA, USA.",
40598392,BM study: a monocentric prospective observational cohort study on neonatal humoral immunity against COVID-19 secondary to transplacental antibody transfer and breastfeeding.,2025 Jul 1,,,
40597698,Over- and under-estimation of vaccine effectiveness.,2025 Jul 1,Aran D,"Current address: Public Health Services, Ministry of Health, Jerusalem, Israel.",
40597327,False-positive reactivity of fourth-generation HIV enzyme immunoassay caused by COVID-19 and other infections.,2025 Jul 1,,,
40596958,Indicators of vaccination status in patients with chronic kidney disease: the importance of recommendations from healthcare providers.,2025 Jul 1,,,
40596750,"April 2025 ACIP Meeting Update: Influenza, COVID-19, HPV, RSV and Other Immunizations.",2025 Jul 2,,,
40596654,Long-term spatial patterns in COVID-19 booster vaccine uptake.,2025 Jul 1,,,
40595733,Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke.,2025 Jul 1,,,
40595446,Influenza and pneumococcal vaccines uptake among pharmacists: systematic review and meta-analysis.,2025 Jul 1,Switalski J,"Department of Health Policy Programs, Department of Health Technology Assessment, Agency for Health Technology Assessment and Tariff System, Warsaw, Poland.",
40595400,"Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.",2025 Jul 2,Corsini CA; da Silva Martins PF; Filgueiras PS; Lourenco AJ; de Souza Lima AE; Gomes SVC; Alves PA; da Rocha Fernandes G; Castro LLME; Teixeira-Carvalho A; Azevedo ACC; De Almeida Leitao Curimbaba C; Lorencini DA; Junior EM; da Silva VM; Nogueira ML; Campos GRF; Dos Reis JGAC; de Sousa Reis EV; Dos Reis Castilho L; Filho OAM; Grenfell RFQE,"Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Oswaldo Cruz Foundation (FIOCRUZ), 1715 Augusto de Lima Avenue, Belo Horizonte, Minas Gerais, 30190-002, Brazil.; Instituto Butantan, Sao Paulo, Sao Paulo, 05503-900, Brazil.; Instituto Butantan, Sao Paulo, Sao Paulo, 05503-900, Brazil.; Instituto Butantan, Sao Paulo, Sao Paulo, 05503-900, Brazil.; Instituto Butantan, Sao Paulo, Sao Paulo, 05503-900, Brazil.; Serrana Clinical Research Center. 438, 13 de Maio, Centro, Serrana, Sao Paulo, 14150-000, Brazil.; Faculty of Medicine of Sao Jose Do Rio Preto (FAMERP), 5416 Brigadeiro Faria Lima Avenue, Sao Jose Do Rio Preto, Sao Paulo, 15090-000, Brazil.; Faculty of Medicine of Sao Jose Do Rio Preto (FAMERP), 5416 Brigadeiro Faria Lima Avenue, Sao Jose Do Rio Preto, Sao Paulo, 15090-000, Brazil.; Belo Horizonte Municipal Health Department (SMS), 2336 Afonso Pena Avenue, Belo Horizonte, 30130-012, Brazil.; Belo Horizonte Municipal Health Department (SMS), 2336 Afonso Pena Avenue, Belo Horizonte, 30130-012, Brazil.; Serrana Clinical Research Center. 438, 13 de Maio, Centro, Serrana, Sao Paulo, 14150-000, Brazil.; Serrana Clinical Research Center. 438, 13 de Maio, Centro, Serrana, Sao Paulo, 14150-000, Brazil.",
40595319,Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia.,2025 Jul 1,Barman M; Giribabu N,"Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.; Department of Physiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.",
40595074,Evaluating miscarriage incidence after COVID-19 vaccination.,2025 Jul 1,,,
40594764,Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals.,2025 Jul 1,Jeong SI; Song JY; Lee IC,"Rnagene Co., Ltd., 603-605, 7 Beobwon-ro 6-gil, Songpa-gu, Seoul-si, 05855, Republic of Korea.; Rnagene Co., Ltd., 603-605, 7 Beobwon-ro 6-gil, Songpa-gu, Seoul-si, 05855, Republic of Korea.; Rnagene Co., Ltd., 603-605, 7 Beobwon-ro 6-gil, Songpa-gu, Seoul-si, 05855, Republic of Korea.",
40594658,A NoSQL document based eCRF system for study of vaccines with variable adverse events case study on COVID19 vaccines.,2025 Jul 1,,,
40594462,A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting.,2025 Jul 1,Anuar ND; Tan TM,"Sengenics Corporation, Level M, Plaza Zurich, Damansara Heights, 50490, Kuala Lumpur, Malaysia.; Sengenics Corporation, Level M, Plaza Zurich, Damansara Heights, 50490, Kuala Lumpur, Malaysia.",
40594178,Tough talks COVID-19 (TT-C) digital health intervention: multistate randomized controlled trial.,2025 Jul 1,Stoner MCD; Browne E; Michaels J; Mancuso N; Larsen MA; Maragh-Bass AC; Comello MLG,"RTI, Research Triangle Park, Chapel Hill, NC, United States.; RTI, Research Triangle Park, Chapel Hill, NC, United States.; RTI, Research Triangle Park, Chapel Hill, NC, United States.; RTI, Research Triangle Park, Chapel Hill, NC, United States.; Virtually Better, Inc, Decatur, GA, USA.; Behavioral, Epidemiological, Clinical Sciences Division, FHI 360, Durham, NC, England.; Behavioral, Epidemiological, Clinical Sciences Division, FHI 360, Durham, NC, England.",
40593808,Age-associated defect in ADCC response to COVID-19 vaccine.,2025 Jul 1,,,
40593795,Identification of SARS-CoV-2-binding lectins on a commercial lectin array.,2025 Jul 1,,,
40593765,Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.,2025 Jul 1,Neumann J; Veiga R; Etienne I; Depickere S; Olislagers V; Waegemans A; Bucken L; Goossens ME; Desombere I; Le Moine A; Marchant A; Humblet-Baron S,"Department of Nephrology, Dialysis and Renal Transplantation, H.U.B. Erasme, Universite libre de Bruxelles (ULB), Brussels, Belgium.; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.; VIB Center for Brain and Disease Research, Leuven, Belgium.; Chest Department, H.U.B. Erasme, Universite libre de Bruxelles (ULB), Brussels, Belgium.; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.; Department of Nephrology, Dialysis and Renal Transplantation, H.U.B. Erasme, Universite libre de Bruxelles (ULB), Brussels, Belgium.; Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium.; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.; Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium.; Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium.; KU Leuven, Department of Microbiology, Immunology and Transplantation, Leuven, Belgium.",
40593634,Extracting circumstances of Covid-19 transmission from free text with large language models.,2025 Jul 1,Bizel-Bizellot G; Galmiche S; Charmet T; Coudeville L; Fontanet A; Zimmer C,"Institut Pasteur, Universite Paris Cite, Imaging and Modeling Unit, Paris, France.; Institut Pasteur, Universite Paris Cite, Epidemiology of Emerging Diseases Unit, Paris, France.; Institut Pasteur, Universite Paris Cite, Imaging and Modeling Unit, Paris, France.; Institut Pasteur, Universite Paris Cite, Image Analysis Hub, Paris, France.; Institut Pasteur, Universite Paris Cite, Epidemiology of Emerging Diseases Unit, Paris, France.; Sanofi Vaccines, Global Medical, Lyon, France.",
40592905,Global estimates of vaccine-associated narcolepsy from 1967 to 2023.,2025 Jul 1,,,
40592802,Inactivated Mycobacterial Vaccine Nebulized Inhalation: A Effective Therapy for the Prevention and Treatment of Respiratory Diseases?,2025,,,
40592680,SEPAR Recommendations on Vaccination for Chronic Respiratory Patients.,2025 Jun 17,Menendez Villanueva R; Cabrera Martinez MM,"Instituto de Investigacion Sanitaria La Fe, Valencia, Spain.; Enfermera de Atencion Primaria, Adeje, Servicio Canario de la Salud, Gerencia de Santa Cruz de Tenerife, Spain.",
40591528,Influenza Vaccination Coverage and Determinants of New Vaccinations During the COVID-19 Pandemic in Spain (ENE-COVID): Nationwide Population-Based Study.,2025 Jul 1,de la Camara MA; Pastor-Barriuso R; Larrauri A; Fernandez-Navarro P; Pollan M; Perez-Gomez B,"National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.",
40591130,Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial.,2025 Jul 1,Diya O; Gayed J; Mensa F; Cutler M; Belanger T; Cooper D; Tureci O; Sahin U; Swanson KA; Modjarrad K; Anderson AS; Gurtman A; Kitchin N,"Vaccine Research and Development, Pfizer Ltd, Marlow, UK.; Vaccine Research and Development, Pfizer Ltd, Marlow, UK. juleen.gayed@pfizer.com.; BioNTech, Mainz, Germany.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; BioNTech, Mainz, Germany.; BioNTech, Mainz, Germany.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.; Vaccine Research and Development, Pfizer Ltd, Marlow, UK.",
40590561,COVID-19 Risk in Patients with Autoimmune Diseases Using Biologics or Small Molecules: A Population-Based Cohort Study.,2025 Jul 1,,,
40590260,Developing the next-generation of adenoviral vector vaccines.,2025 Dec,,,
40589754,A novel and safe SmartCap((R)) SC101 to develop the COVID-19 mRNA vaccine STP2104 inducing potent immune responses in humans.,2025,Kim R; Uhm TG; Kim J; Woo D; Kim UI; Meng X; Yang B; Kim S; Kim H; Kim J; Lee JY; Kim B; Cho D; Chang D; Cho YH; Choi K; Lee HW; Bang J; Hellstrom E; Kim K; Yang JS,"R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; Be Part Research (PTY) Ltd., Paarl, South Africa.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.; R&D Center, ST Pharm Co., Ltd., Seoul, Republic of Korea.",
40589223,Editorial: The 2025 World Health Assembly Pandemic Agreement and the 2024 Amendments to the International Health Regulations Combine for Pandemic Preparedness and Response.,2025 Jul 1,Parums DV,"Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.",
